Cardinal Health (NYSE:CAH) Price Target Raised to $129.00

Cardinal Health (NYSE:CAH - Get Free Report) had its price target boosted by analysts at Citigroup from $120.00 to $129.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a "neutral" rating on the stock. Citigroup's price target points to a potential upside of 6.00% from the stock's previous close.

A number of other analysts have also commented on the stock. Barclays lifted their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research note on Monday, November 4th. Wells Fargo & Company upgraded Cardinal Health from an "underweight" rating to an "equal weight" rating and increased their target price for the company from $101.00 to $127.00 in a research report on Friday, December 13th. Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 target price on the stock. Deutsche Bank Aktiengesellschaft upped their target price on Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a report on Monday, November 4th. Finally, Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target for the company in a report on Tuesday. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $133.29.

Cardinal Health Trading Down 0.7 %

CAH stock traded down $0.83 during midday trading on Friday, hitting $121.70. The company had a trading volume of 1,974,292 shares, compared to its average volume of 2,267,382. The stock's 50 day moving average price is $119.77 and its 200 day moving average price is $110.84. Cardinal Health has a 52 week low of $93.17 and a 52 week high of $126.23. The stock has a market cap of $29.45 billion, a price-to-earnings ratio of 23.68, a PEG ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm's quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.73 earnings per share. Analysts predict that Cardinal Health will post 7.82 earnings per share for the current year.

Hedge Funds Weigh In On Cardinal Health

A number of institutional investors and hedge funds have recently bought and sold shares of CAH. Point72 Asset Management L.P. acquired a new stake in Cardinal Health during the 2nd quarter valued at $90,440,000. State Street Corp increased its stake in shares of Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company's stock valued at $1,566,913,000 after buying an additional 627,253 shares in the last quarter. Pacer Advisors Inc. raised its holdings in shares of Cardinal Health by 9.9% in the second quarter. Pacer Advisors Inc. now owns 4,099,082 shares of the company's stock valued at $403,022,000 after buying an additional 370,181 shares during the last quarter. Two Sigma Advisers LP lifted its position in Cardinal Health by 47.9% during the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock worth $118,197,000 after buying an additional 346,362 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec increased its position in Cardinal Health by 230.0% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company's stock valued at $52,819,000 after acquiring an additional 333,095 shares in the last quarter. Institutional investors own 87.17% of the company's stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.